Rafferty Asset Management
ALXO icon

Rafferty Asset Management’s ALX Oncology ALXO Stock Holding History

Rafferty Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-156,876
Closed -$2.65M – 1130
2022
Q1 		$2.65M Buy
156,876
+49,896
+47% +$852K 0.02% 532
2021
Q4 		$2.3M Buy
+106,980
New +$4.61M 0.01% 607
2021
Q3 		– Sell
-43,721
Closed -$2.39M – 1259
2021
Q2 		$2.39M Buy
43,721
+538
+1% +$32.2K 0.02% 627
2021
Q1 		$3.18M Buy
43,183
+39,982
+1,249% +$3.15M 0.02% 452
2020
Q4 		$276K Buy
+3,201
New +$193K ﹤0.01% 850

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Rafferty Asset Management's ALXO Position: Q2 2022 in Review

Rafferty Asset Management sold out of ALX Oncology (ALXO) in Q2 2022, closing a stake of 156,876 shares — an estimated $2.65M sold.

Rafferty Asset Management first reported a position in ALXO in Q4 2020 and held it in 5 quarters. The position peaked at $3.18M in Q1 2021. 97 funds tracked by Wall St. Rank hold ALXO as of Q2 2022.

  • Rafferty Asset Management reported no remaining ALX Oncology position as of Q2 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 156,876 ALX Oncology shares in Q2 2022, an estimated $2.65M.
  • Rafferty Asset Management first reported a position in ALX Oncology in Q4 2020 and held it in 5 quarters.
  • Rafferty Asset Management's ALX Oncology position peaked at $3.18M in Q1 2021.
  • 97 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.